Treatment of refractory melasma with the MedLite C6 Q-switched Nd:YAG laser and alpha arbutin: A prospective study

Journal of Cosmetic and Laser Therapy

Volumn 12, Issue 3, 2010, Pages 126-131

  Polnikorn, Niwat ^a  

^a Kasemrad Prachacheun Hospital   (Thailand)

Author keywords

Lasers and light sources; Topical agents

Indexed keywords

ALPHA ARBUTIN; ARBUTIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHLOASMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; ERYTHEMA; FEMALE; HAIR DISCOLORATION; HUMAN; MEDICAL PHOTOGRAPHY; NEODYMIUM LASER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REFRACTORY MELASMA; SKIN DISCOMFORT; SWITCHED LASER; TREATMENT DURATION; URTICARIA;

ADULT; ARBUTIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LASER THERAPY, LOW-LEVEL; LASERS, SOLID-STATE; MELANOSIS; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 77952651409     PISSN: 14764172     EISSN: 14764180     Source Type: Journal    
DOI: 10.3109/14764172.2010.487910     Document Type: Article

References (26)

1. Gupta AK, Gover MD, Nouri K, Taylor S. The treatment of melasma: A review of clinical trials. J Am Acad Dermatol.2006;55:1048-65.
2. Prignano F, Ortanne JP, Buggiani G, Lotti T. Therapeutic approaches in melasma. Dermatol Clin.2007;25:337-42.
3. Grimes PE. Melasma: Etiologic and therapeutic consideration. Arch Dermatol.1995;131:1453-7.
4. Kang WH, Yoon KH, Lee ES, Kim J, Lee KB, Yim H, et al. Melasma: Histopathological characteristics in 56 Korean patients. Br J Dermatol.2002;146:228-37.
5. Cestari TF, Hassun K, Sittart A, Viegas MdL. A comparison of triple combination cream and hydroquinone 4% cream for the treatment of moderate to severe facial melasma. J Cosmet Dermatol.2007;6:36-9.
6. Haddad AL, Matos LF, Bruenstein F, Ferreira LM, Silva A, Costa D Jr. A clinical, prospective, randomized, double-blind trial comparing skin whitening complex with hydroquinone vs. placebo in treatment of melasma. Int J Dermatol.2003;42:153-6.
7. Kligman AM, Willis I. A new formula for depigmentating human skin. Arch Dermatol.1975;111:40-8.
8. Taylor SC, Torok H, Jones T, Lowe N, Rich P, Tschen E, et al. Efficacy and safety of a new triple-combination agent for the treatment of facial melasma. Cutis.2003;72:67-72.
9. Maeda K, Fukuda M. Arbutin: Mechanism of its depigmenting action in human melanocyte culture. J Pharmacol Exp Ther.1996;276:765-9.
10. Chakarborty AK, Funasaka Y, Komoto M, Ichihasshi M. Effect of arbutin on melanogenic proteins in human melanocytes. Pigment Cell Res.1998;11:206-12.
11. Sugimoto K, Nishimura T, Nomura K, Sugimoto K, Kuriki T. Syntheses of arbutin alpha glycosides and a comparison of their inhibitory effects with those of alpha arbutin and arbutin on human tyrosinase. Chem Pharm Bull (Tokyo).2003;51:798-801.
12. Kopora D, Hohenleutner U. Ruby laser treatment of melasma and post inflammatory hyperpigmentation. Dermatol Surg.1995;21:990-5.
13. Lipper GM, Anderson RR. Lasers in dermatology. In: Freedberg IM, Eisen AZ, Wolf K, et al., editors. Fitzpatrick dermatology in general medicine. New York: McGraw Hill; 2003. pp. 2508-9.
14. Rusciani A, Motta A, Rusciani L, Alfano. Q-switched alexandrite laser-assisted treatment of melasma, 2 years follow up monitoring. J Drugs Dermatol.2005;6:770-4.
15. Palumbo A, d'Ischia M, Misuraca G, Procta G. Mechanism of inhibition of melanogenesis by hydroquinone. Biochem Biophysic Acta.1991;1073:85-90.
16. Lim JT. Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid. Dermatol Surg.1999;25:282-4.
17. Huerta Brogeras M, Sanchez Vira M. Exogenous ochronosis. J Drugs Dermatol.2006;5:80-1.
18. Balina LM, Graupe K. The treatment of melasma: 20% azaleic acid versus 4% hydroquinone cream. Int J Dermatol.1991;30:893-5.
19. Kunachak S, Leedaudomlipi P, Wongwaisayawan S. Dermabrasion: A curative treatment for melasma. Aesthetic Plast Surg.2001;25:114-17.
20. Nouri K, Bowes L, Chartier T, Romangosa R, Spencer J. Combination treatment of melasma with pulsed CO 2 laser followed by Q-switched alexandrite laser: A pilot study. Dermatol Surg.1999;25:494-7.
21. Angsuwarangsee S, Polnikorn N. Combination ultrapulse CO 2 laser and Q-switched alexandrite laser compared with Q-switched alexandrite laser alone for refractory melasma. Dermatol Surg.2003;29:59-64.
22. Malaloto RM, Alster T. Erbium-YAG laser resurfacing for refractory melasma. Dermatol Surg.1999;25:121-3.
23. Rokhsar CK, Fitzpatrick RE. The treatment of melasma with fractional photothermolysis: A pilot-study. Dermatol Surg.2005;31:1645-50.
24. Naito SK. Fractional photothermolysis treatment for resistant melasma in Chinese female. J Cosmet Laser Ther.2007;9:161-3.
25. Hantash BM, Bedi VP, Sudireddy V, Struck SK, Herron GS, Chan KF. Laser-induced transepidermal elimination of dermal content by fractional thermolysis. J Biomed Opt.2006;11:04115.
26. Tannous ZS, Astner S. Utilizing fractional resurfacing in therapy resistant melasma. J Cosmet Laser Ther.2005;7:39-43.